ArticleJournal of cancer research and clinical oncology2021

Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.

Ji Hyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.